EXOSOMAL TETRASPANINS: THE ROLE OF CD63 AND CD81 IN THE PATHOGENESIS OF MYOCARDIAL INFARCTION
- Authors: Reviakina M.O.1, Kabina N.A.1
-
Affiliations:
- FSBEI of HE "Orel State University named after I.S. Turgenev ", Komsomolskaya street, Orel, Russia
- Section: Immunological readings in Chelyabinsk
- Submitted: 30.03.2025
- Accepted: 25.05.2025
- URL: https://rusimmun.ru/jour/article/view/17211
- DOI: https://doi.org/10.46235/1028-7221-17211-ETT
- ID: 17211
Cite item
Full Text
Abstract
Abstract
Cardiovascular diseases are one of the major global health problems with high prevalence and mortality rates. Complex intercellular communications supported by circulating exosomes, recognized as important participants in the immunopathogenesis of atherosclerosis and coronary heart disease, play a crucial role in the pathogenesis and progression of cardiovascular diseases. Considering that tetraspanins (CD63 and CD81) are widely recognized as exosomal markers, the purpose of our study was to determine and evaluate the dynamics of serum production of exosomal tetraspanins CD63 and CD81 on 1 and 7th days of acute myocardial infarction. Materials and methods. The study included 40 patients with acute myocardial infarction (AMI) aged 54.29±5.45 years and 10 healthy ones, age and gender matched. Research results. AMI revealed two types of dynamics of tetraspanin production in acute ischemic process in the myocardium. Type 1 is characterized by initially low values of tetraspanin CD63, compared to healthy individuals, and is accompanied by an increase in the production/release of exosomal CD63 on day 7; type 2 is with higher CD63 values, exceeding those of healthy individuals on day 1 of the pathological process with AMI decrease in their concentration by day 7. Our correlation analysis of tetraspanin CD63 allowed us to establish links with age, cholesterol, LDL, triglycerides and the number of platelets and leukocytes. The CD81 level in patients with AMI in the blood serum was significantly lower than in healthy individuals. The identified features of the production dynamics allowed us to classify patients by types: 1 - with an increase in serum exosomal CD81 and subsequent achievement of the target tetraspanin level typical for healthy individuals; 2 - with a decrease in concentration compared to the initial level, combined with a higher frequency of adverse cardiovascular events. The correlation analysis of serum CD81 allowed us to establish correlations with the level of leukocytes and erythrocyte sedimentation rate and obesity degree. Conclusions. The exosomal profile of circulating CD63 and CD81 in individuals with AMI differs in its quantitative characteristics from healthy subjects, and characterized by different types of dynamics of tetraspanin production during the first week of myocardial infarction.
Keywords
About the authors
Mariia O. Reviakina
FSBEI of HE "Orel State University named after I.S. Turgenev ",Komsomolskaya street, Orel, Russia
Email: moplotnikova@mail.ru
SPIN-code: 4921-7530
Scopus Author ID: 57326361600
Candidate of Medical Sciences, Associate Professor of the Department of Immunology and Specialized Clinical Disciplines
Russian Federation, Komsomolskaya street,95, Orel, 302026, RussiaNataliya A. Kabina
FSBEI of HE "Orel State University named after I.S. Turgenev ",Komsomolskaya street, Orel, Russia
Author for correspondence.
Email: apt53boss@mail.ru
SPIN-code: 5103-2264
research fellow at the Laboratory of New Medical Technologies of the Orel State University named after I.S. Turgenev
Russian Federation, Komsomolskaya street,95, Orel, 302026, RussiaReferences
- Snimshhikova I.A., Kabina N.A., Plotnikova M.O., Kiseleva M.V. Prospects for studying tetraspanin CD9 in the pathogenesis of myocardial infarction. Journal of Ural medical academic science, 2024, Vol. 21, no. 3, pp. 223-232.
- Burrello J., Bolis S., Balbi C., Burrello A., Provasi E., Caporali E., Gauthier L.G., Peirone A., D'Ascenzo F., Monticone S., Barile L., Vassalli G. An extracellular vesicle epitope profile is associated with acute myocardial infarction. Journal of cellular and molecular medicine, 2020, Vol. 24, no. 17, pp. 9945–9957. doi: 10.1111/jcmm.15594.
- Chong B., Jayabaskaran J., Jauhari S.M., Chan S.P., Goh R., Kueh M.T.W., Li H., Chin Y.H., Kong G., Anand V.V., Wang J.-W., Muthiah M., Jain V., Mehta A., Lim S.L., Foo R., Figtree G.A., Nicholls S.J., Mamas M.A., Januzzi J.L., Chew N., Richards A.M., Chan M.Y. Global burden of cardiovascular diseases: projections from 2025 to 2050. European Journal of Preventive Cardiology, 2024, September, pp. 1-15. doi: 10.1093/eurjpc/zwae281.
- Fan Y., Pionneau C., Cocozza F., Boëlle P., Chardonnet S., Charrin S., Théry C., Zimmermann P., Rubinstein E. Differential proteomics argues against a general role for CD9, CD81 or CD63 in the sorting of proteins into extracellular vesicles. Journal of Extracellular Vesicles, 2023, Vol. 12, no. 8, e12352. doi: 10.1002/jev2.12352.
- Gao X.F., Wang Z.M., Wang F., Gu Y., Zhang J.J., Chen S.L. Exosomes in Coronary Artery Disease. International Journal of Biological Sciences, 2019, Vol. 15, no. 11, pp. 2461-2470. doi: 10.7150/ijbs.36427.
- Kalluri R., LeBleu V.S. The biology, function and biomedical applications of exosomes. Science, 2020, Vol. 367, no. 6478, eaau6977. doi: 10.1126/science.aau6977.
- Kestecher B., Németh K., Ghosal S., Sayour N.V., Gergely T.G., Bodnár B.R., Försönits A., Sódar B.W., Oesterreicher J., Holnthoner W., Varga Z.V., Giricz Z., Ferdinandy P., Buzás E.I., Osteikoetxea X. Reduced circulating CD63+ extracellular vesicle levels associate with atherosclerosis in hypercholesterolaemic mice and humans. Cardiovascular Diabetology, 2024, Vol. 23, no. 1, p. 368. doi: 10.1186/s12933-024-02459-w.
- Martins-Marques T. Connecting different heart diseases through intercellular communication. Biology Open, 2021, Vol. 10, no. 9, pp. 1-12. doi: 10.1242/BIO.058777.
- Røsand Ø., Høydal M.A. Cardiac Exosomes in Ischemic Heart Disease - A Narrative Review. Diagnostics, 2021, Vol. 11, no. 2, p. 269. doi: 10.3390/diagnostics11020269.
- Saint-Pol J., Fenart L. CD63, a new therapeutical candidate for cholesterol homeostasis regulation through extracellular vesicles? Extracellular Vesicles and Circulating Nucleic Acids, 2025, Vol. 6, pp. 166-170. doi: 10.20517/evcna.2024.92.
- Schmidt S.C., Massenberg A., Homsi Y., Sons D., Lang T. Microscopic clusters feature the composition of biochemical tetraspanin-assemblies and constitute building-blocks of tetraspanin enriched domains. Dental science reports, 2024, Vol. 14, no. 1, st. 2093. doi: 10.1038/s41598-024-52615-1.
- Seth S.M., Aaron W.A., Norrina B.A., Almarzooq Z.I. at al. 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association. Circulation, Vol. 151, no. 8, pp. e41–e660. doi: 10.1161/CIR.0000000000001303.
Supplementary files
